REG - CVS Group plc - PDMR Dealing

CVSAnnouncement

08/12/2025 17:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251208:nRSH7214Ka&default-theme=true

RNS Number : 7214K  CVS Group plc  08 December 2025

8 December 2025

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary
services, announces that it was notified on 5(th) & 8th December 2025
respectively of the following share purchases:

·    Paul Higgs, Director and Chief Veterinary Officer of the Company
purchased 1,235 Ordinary Shares.  As a result Paul Higgs's total interest in
the Company is now 4,931 Ordinary shares, representing 0.007 per cent of the
total voting rights of the Company.

·    Joanne Shaw, Non-Executive Director of the Company purchased 825
Ordinary Shares.  As a result Joanne Shaw's total interest in the Company is
now 2,387 Ordinary shares, representing 0.003 per cent of the total voting
rights of the Company.

The notifications below, made in accordance with the requirements of UK MAR,
provide further detail.

Contacts:

CVS Group plc
 
             via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)
                                 +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial
PR)

Ginny Pulbrook
 
              +44 (0)7961 315 138

   Letaba Rimell

   Tilly Butcher

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Paul Higgs

 2    Reason for the notification

 a)   Position/status                                              PDMR (Director and Chief Veterinary Officer)

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    On-market purchase

 c)   Price(s) and volume(s)

Price(s) - pence  Volume(s)

                                                                   1,213.996         1,235
 d)   Aggregated information

                                                                   N/A - single transaction

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      5 December 2025

 f)   Place of the transaction                                     London Stock Exchange - AIM (XLON)

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

N/A - single transaction

e)

 

Date of the transaction

 

 

5 December 2025

f)

 

Place of the transaction

 

London Stock Exchange - AIM (XLON)

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Joanne Shaw

 2    Reason for the notification

 a)   Position/status                                              PDMR (Non-Executive Director)

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    On-market purchase

 c)   Price(s) and volume(s)

Price(s) - pence  Volume(s)

                                                                   1,210.679         825
 d)   Aggregated information

                                                                   N/A - single transaction

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      5 December 2025

 f)   Place of the transaction                                     London Stock Exchange - AIM (XLON)

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

N/A - single transaction

e)

 

Date of the transaction

 

 

5 December 2025

f)

 

Place of the transaction

 

London Stock Exchange - AIM (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHDVLFBELLXFBD



            Copyright 2019 Regulatory News Service, all rights reserved